tert-Butyl piperazine-1-carboxylate → HCID 69735871, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][N:5]=[C:4]2[CH:8]=[C:9]([C:11]([O-:13])=O)[S:10][C:3]=12.[Li+].[C:15]([O:19][C:20]([N:22]1[CH2:27][CH2:26][NH:25][CH2:24][CH2:23]1)=[O:21])([CH3:18])([CH3:17])[CH3:16]>>[C:15]([O:19][C:20]([N:22]1[CH2:27][CH2:26][N:25]([C:11]([C:9]2[S:10][C:3]3[C:4](=[N:5][CH:6]=[CH:7][C:2]=3[Cl:1])[CH:8]=2)=[O:13])[CH2:24][CH2:23]1)=[O:21])([CH3:18])([CH3:16])[CH3:17]Participants
3
Procedure
The title compound was prepared from lithium 7-chloro-thieno[3,2-b]pyridine-2-carboxylate and piperazine-1-carboxylic acid tert-butyl ester by a procedure analogous to Example 1B. MS: 383 (MH+); HPLC Rf: 5.69; HPLC purity: 99%.
Sources & evidence
- ORD record
- ord-6feb494269ab408dac824ff1d6b127e1
- Source dataset
- uspto-grants-2005_11
- Patent number
- US06964961B2
Reaction notes
Loading…